# | Title | Journal | Year | Citations |
---|
|
1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | PLoS Medicine | 2009 | 52,826 |
2 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | Journal of Clinical Epidemiology | 2009 | 9,992 |
3 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | BMC Medicine | 2010 | 5,246 |
4 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 4,731 |
5 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 4,451 |
6 | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies | Lancet, The | 2017 | 4,080 |
7 | Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Lancet, The | 1998 | 3,410 |
8 | Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews | BMC Medical Research Methodology | 2007 | 3,350 |
9 | Lost in knowledge translation: Time for a map? | Journal of Continuing Education in the Health Professions | 2006 | 3,218 |
10 | The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement | PLoS Medicine | 2015 | 3,168 |
11 | PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement | Journal of Clinical Epidemiology | 2016 | 2,849 |
12 | Genome-wide association studies for complex traits: consensus, uncertainty and challenges | Nature Reviews Genetics | 2008 | 2,523 |
13 | Audit and feedback: effects on professional practice and healthcare outcomes | The Cochrane Library | 2012 | 2,260 |
14 | Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies | JAMA - Journal of the American Medical Association | 2018 | 1,962 |
15 | Scoping reviews: time for clarity in definition, methods, and reporting | Journal of Clinical Epidemiology | 2014 | 1,894 |
16 | A systematic review of low back pain cost of illness studies in the United States and internationally | Spine Journal | 2008 | 1,654 |
17 | Knowledge translation of research findings | Implementation Science | 2012 | 1,653 |
18 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 1,623 |
19 | A comparison of direct vs. self‐report measures for assessing height, weight and body mass index: a systematic review | Obesity Reviews | 2007 | 1,594 |
20 | AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews | Journal of Clinical Epidemiology | 2009 | 1,459 |
21 | Developing a quality criteria framework for patient decision aids: online international Delphi consensus process | BMJ: British Medical Journal | 2006 | 1,410 |
22 | The Canadian CT Head Rule for patients with minor head injury | Lancet, The | 2001 | 1,309 |
23 | Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement | Journal of Clinical Epidemiology | 2021 | 1,244 |
24 | Increasing value and reducing waste in research design, conduct, and analysis | Lancet, The | 2014 | 1,234 |
25 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 1,194 |
26 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | Trials | 2010 | 1,189 |
27 | CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials | PLoS Medicine | 2010 | 1,187 |
28 | Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging | American Journal of Epidemiology | 2002 | 1,052 |
29 | Guidance for Developers of Health Research Reporting Guidelines | PLoS Medicine | 2010 | 974 |
30 | Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials | PLoS ONE | 2012 | 931 |
31 | New Canadian Physical Activity Guidelines | Applied Physiology, Nutrition and Metabolism | 2011 | 907 |
32 | CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials | Journal of Pharmacology and Pharmacotherapeutics | 2010 | 884 |
33 | Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement | PLoS Medicine | 2010 | 840 |
34 | Evidence summaries: the evolution of a rapid review approach | Systematic Reviews | 2012 | 814 |
35 | CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials | Journal of Clinical Epidemiology | 2010 | 795 |
36 | The threat of antimicrobial resistance in developing countries: causes and control strategies | Antimicrobial Resistance and Infection Control | 2017 | 792 |
37 | A brief clinical instrument to classify frailty in elderly people | Lancet, The | 1999 | 776 |
38 | Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | 2007 | 763 |
39 | Toxicity Testing in the 21st Century: A Vision and a Strategy | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | 2010 | 756 |
40 | Specifying and reporting complex behaviour change interventions: the need for a scientific method | Implementation Science | 2009 | 744 |
41 | Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review | Medical Journal of Australia | 2006 | 736 |
42 | Selecting Patients With Atrial Fibrillation for Anticoagulation | Circulation | 2004 | 731 |
43 | Decision aids for patients facing health treatment or screening decisions: systematic review | BMJ: British Medical Journal | 1999 | 726 |
44 | Epidemiology and Reporting Characteristics of Systematic Reviews | PLoS Medicine | 2007 | 712 |
45 | Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies | Circulation | 2014 | 709 |
46 | Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study | Lancet, The | 2008 | 708 |
47 | The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development | Headache | 2013 | 707 |
48 | Controversies in RBC Transfusion in the Critically Ill | Chest | 2007 | 687 |
49 | Teenage pregnancy and adverse birth outcomes: a large population based retrospective cohort study | International Journal of Epidemiology | 2007 | 674 |
50 | The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development | Global Advances in Health and Medicine | 2013 | 660 |